Utah Medical Products Current Ratio 2010-2025 | UTMD
Utah Medical Products current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Utah Medical Products Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.10B | $0.00B | 22.29 |
| 2024-12-31 | $0.10B | $0.00B | 25.64 |
| 2024-09-30 | $0.10B | $0.00B | 29.59 |
| 2024-06-30 | $0.10B | $0.00B | 25.98 |
| 2024-03-31 | $0.11B | $0.01B | 19.57 |
| 2023-12-31 | $0.11B | $0.01B | 22.56 |
| 2023-09-30 | $0.10B | $0.00B | 24.38 |
| 2023-06-30 | $0.10B | $0.01B | 19.21 |
| 2023-03-31 | $0.10B | $0.01B | 15.66 |
| 2022-12-31 | $0.09B | $0.01B | 15.09 |
| 2022-09-30 | $0.08B | $0.01B | 13.44 |
| 2022-06-30 | $0.08B | $0.00B | 17.79 |
| 2022-03-31 | $0.08B | $0.01B | 13.03 |
| 2021-12-31 | $0.07B | $0.00B | 19.54 |
| 2021-09-30 | $0.08B | $0.01B | 15.12 |
| 2021-06-30 | $0.07B | $0.00B | 15.93 |
| 2021-03-31 | $0.07B | $0.01B | 14.59 |
| 2020-12-31 | $0.06B | $0.00B | 16.42 |
| 2020-09-30 | $0.06B | $0.00B | 15.79 |
| 2020-06-30 | $0.05B | $0.00B | 16.38 |
| 2020-03-31 | $0.05B | $0.00B | 13.48 |
| 2019-12-31 | $0.06B | $0.00B | 15.92 |
| 2019-09-30 | $0.05B | $0.00B | 13.43 |
| 2019-06-30 | $0.05B | $0.00B | 12.10 |
| 2019-03-31 | $0.05B | $0.01B | 6.48 |
| 2018-12-31 | $0.06B | $0.01B | 11.58 |
| 2018-09-30 | $0.06B | $0.01B | 12.38 |
| 2018-06-30 | $0.06B | $0.01B | 10.67 |
| 2018-03-31 | $0.05B | $0.01B | 10.38 |
| 2017-12-31 | $0.05B | $0.01B | 9.32 |
| 2017-09-30 | $0.05B | $0.01B | 9.27 |
| 2017-06-30 | $0.04B | $0.00B | 9.97 |
| 2017-03-31 | $0.04B | $0.01B | 7.55 |
| 2016-12-31 | $0.03B | $0.00B | 11.41 |
| 2016-09-30 | $0.04B | $0.01B | 7.58 |
| 2016-06-30 | $0.04B | $0.01B | 7.57 |
| 2016-03-31 | $0.04B | $0.01B | 6.04 |
| 2015-12-31 | $0.03B | $0.00B | 8.09 |
| 2015-09-30 | $0.03B | $0.01B | 5.63 |
| 2015-06-30 | $0.03B | $0.01B | 5.62 |
| 2015-03-31 | $0.03B | $0.01B | 5.00 |
| 2014-12-31 | $0.03B | $0.01B | 3.31 |
| 2014-09-30 | $0.03B | $0.01B | 3.12 |
| 2014-06-30 | $0.03B | $0.01B | 3.10 |
| 2014-03-31 | $0.03B | $0.01B | 3.08 |
| 2013-12-31 | $0.02B | $0.01B | 3.19 |
| 2013-09-30 | $0.03B | $0.01B | 2.66 |
| 2013-06-30 | $0.02B | $0.01B | 2.59 |
| 2013-03-31 | $0.02B | $0.01B | 2.39 |
| 2012-12-31 | $0.02B | $0.01B | 2.37 |
| 2012-09-30 | $0.02B | $0.01B | 1.76 |
| 2012-06-30 | $0.02B | $0.01B | 1.74 |
| 2012-03-31 | $0.02B | $0.01B | 1.69 |
| 2011-12-31 | $0.02B | $0.01B | 1.77 |
| 2011-09-30 | $0.02B | $0.01B | 1.69 |
| 2011-06-30 | $0.02B | $0.01B | 1.71 |
| 2011-03-31 | $0.02B | $0.01B | 1.60 |
| 2010-12-31 | $0.03B | $0.00B | 13.21 |
| 2010-09-30 | $0.03B | $0.00B | 10.54 |
| 2010-06-30 | $0.03B | $0.00B | 11.56 |
| 2010-03-31 | $0.03B | $0.00B | 8.78 |
| 2009-12-31 | $0.03B | $0.00B | 14.90 |
| 2009-09-30 | $0.03B | $0.00B | 8.84 |
| 2009-06-30 | $0.03B | $0.00B | 10.55 |
| 2009-03-31 | $0.03B | $0.00B | 7.35 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.182B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.634B | 27.97 |
| Boston Scientific (BSX) | United States | $152.531B | 38.19 |
| Stryker (SYK) | United States | $145.427B | 30.41 |
| EssilorLuxottica (ESLOY) | France | $127.535B | 0.00 |
| Medtronic (MDT) | Ireland | $109.709B | 15.55 |
| Haleon (HLN) | United Kingdom | $49.754B | 28.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.468B | 0.00 |
| ResMed (RMD) | United States | $36.224B | 27.21 |
| GE HealthCare Technologies (GEHC) | United States | $32.583B | 15.47 |
| Agilent Technologies (A) | United States | $32.148B | 20.88 |
| Terumo (TRUMY) | Japan | $26.857B | 34.88 |
| Insulet (PODD) | United States | $22.748B | 89.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.431B | 15.40 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.172B | 11.67 |
| Baxter (BAX) | United States | $15.441B | 11.53 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.754B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.002B | 20.89 |
| Lantheus Holdings (LNTH) | United States | $5.375B | 13.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.194B | 18.74 |
| Perrigo (PRGO) | Ireland | $3.646B | 9.24 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.346B | 15.24 |
| ICU Medical (ICUI) | United States | $3.213B | 23.69 |
| Envista Holdings (NVST) | United States | $3.174B | 26.38 |
| GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
| QuidelOrtho (QDEL) | United States | $2.048B | 14.09 |
| LeMaitre Vascular (LMAT) | United States | $1.872B | 41.85 |
| AtriCure (ATRC) | United States | $1.719B | 0.00 |
| Neogen (NEOG) | United States | $1.302B | 16.67 |
| Acuren (TIC) | United States | $1.300B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
| Green Thumb Industries (GTBIF) | United States | $1.110B | 24.97 |
| BioLife Solutions (BLFS) | United States | $1.016B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.986B | 12.60 |
| InMode (INMD) | Israel | $0.930B | 9.37 |
| Evolus (EOLS) | United States | $0.642B | 0.00 |
| CeriBell (CBLL) | United States | $0.612B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.544B | 0.00 |
| Valneva SE (VALN) | France | $0.519B | 0.00 |
| Owens & Minor (OMI) | United States | $0.517B | 4.29 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Surmodics (SRDX) | United States | $0.422B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.326B | 11.98 |
| Aurora Cannabis (ACB) | Canada | $0.302B | 53.70 |
| Cresco Labs (CRLBF) | United States | $0.277B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.268B | 22.63 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.75 |
| Sanuwave Health (SNWV) | United States | $0.242B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.46 |
| Brainsway (BWAY) | Israel | $0.192B | 50.95 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Omeros (OMER) | United States | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.178B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 16.58 |
| Jin Medical (ZJYL) | China | $0.122B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.62 |
| Agape ATP (ATPC) | $0.081B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Nephros (NEPH) | United States | $0.035B | 46.71 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |